Nama Insights

State Street SPDR S&P Pharmaceuticals ETF (XPH)

Health · State Street Investment Management · NYSE

HealthETF
State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund in the Health category. It has $523.98M in assets, an expense ratio of 0.35% and a 0.42% dividend yield. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Assets under management$523.98M
Expense ratio0.35%
CategoryHealth
Dividend yield0.42%
NAV$64.75
Fund familyState Street Investment Management
ExchangeNYSE

Top holdings

The largest positions State Street SPDR S&P Pharmaceuticals ETF reports, by weight.

HoldingNameWeight
XERS Xeris Biopharma Holdings Inc 2.46%
MANE Veradermics Inc 2.42%
AMRX Amneal Pharmaceuticals Inc Ordinary Shares - Class A 2.32%
LGND Ligand Pharmaceuticals Inc 2.15%
VTRS Viatris Inc 2.13%
INDV Indivior Pharmaceuticals Inc Ordinary Share 2.05%
PRGO Perrigo Co PLC 2.05%
LLY Eli Lilly and Co 2.05%
ANIP ANI Pharmaceuticals Inc 2.04%
PFE Pfizer Inc 2.04%

Other Health ETFs

Explore live XPH data on Nama Insights →